Back to top

Image: Bigstock

AVNT Q2 Earnings Top Estimates on Organic Growth, Guidance Up

Read MoreHide Full Article

Key Takeaways

  • Avient's Q2 adjusted EPS rose 20% to 96 cents as sales increased 5.8% to $917 million.
  • Organic sales grew 4.3%, while adjusted EBITDA margin expanded 110 basis points to a record 18.3%.
  • AVNT raised 2026 adjusted EPS guidance to $3.10-$3.25 and EBITDA guidance to $575-$603 million.

Avient Corporation (AVNT - Free Report) reported adjusted earnings of 96 cents per share for the second quarter of 2026, up 20% from 80 cents a year ago. The bottom line beat the Zacks Consensus Estimate of 89 cents by 7.9%. Better-than-expected organic volume growth aided the outperformance.

Sales increased 5.8% year over year to $917 million and beat the Zacks Consensus Estimate of $895.3 million by 2.4%. Organic sales rose 4.3%, while favorable foreign exchange contributed 1.5%. Adjusted EBITDA margin expanded 110 basis points to a record 18.3%.

Avient Corporation Price, Consensus and EPS Surprise

Avient Corporation Price, Consensus and EPS Surprise

Avient Corporation price-consensus-eps-surprise-chart | Avient Corporation Quote

Segment Highlights

Color, Additives and Inks sales increased 6.6% year over year to $574.2 million from $538.6 million. Segment EBITDA rose 10.5% to $124.5 million from $112.7 million. The segment’s EBITDA margin improved to approximately 21.7% from 20.9% in the year-ago quarter.

Specialty Engineered Materials generated sales of $343.9 million, up 4.3% from $329.7 million a year earlier. Segment EBITDA climbed 21.1% to $75.8 million from $62.6 million. EBITDA margin expanded to approximately 22% from 19%, indicating significant profitability improvement in the segment.

Financials

Avient ended the second quarter with cash and cash equivalents of $425.6 million. Total debt was approximately $1.88 billion. For the first six months of 2026, net cash provided by operating activities was $59.3 million. Capital expenditures were $41.3 million. Management expects cash generation to support both growth investments and further balance-sheet improvement.

Outlook

Avient raised its full-year 2026 adjusted earnings guidance to $3.10-$3.25 per share from the previous range of $2.93-$3.17. The revised range implies adjusted earnings growth of 10-15% over 2025. Management cited year-to-date performance and visibility into third-quarter demand in raising its expectations.

The company also increased its full-year adjusted EBITDA guidance to $575-$603 million. AVNT expects to repay $100-$150 million of debt during 2026, including the $50 million repaid in the second quarter. Management remains focused on targeted investments in prioritized growth portfolios while pursuing continued earnings growth and balance-sheet improvement.

AVNT’s Price Performance

Shares of Avient have gained 25.5% in the past year against the 4.3% growth in the industry.

Zacks Investment Research
Image Source: Zacks Investment Research

AVNT’s Zacks Rank & Other Chemicals Releases

AVNT currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Ashland Inc.’s (ASH - Free Report) adjusted earnings were $1.02 per share for the fiscal third quarter, down around 2% from the year-ago quarter’s figure of $1.04. The bottom line missed the Zacks Consensus Estimate of $1.03. For fiscal 2026, Ashland reaffirmed sales guidance of $1.835-$1.870 billion and adjusted EBITDA outlook of $385-$400 million. 

Huntsman Corporation (HUN - Free Report) posted break-even earnings per share on an adjusted basis for the second quarter compared with a loss of 20 cents in the year-ago quarter. The Zacks Consensus Estimate of earnings was pegged at 6 cents per share. HUN expects to remain focused on additional price increases and cost-reduction initiatives to offset rising and volatile energy and crude oil-related costs, particularly in Europe. 

Olin Corporation’s (OLN - Free Report) second-quarter adjusted earnings were 7 cents per share, in line with the Zacks Consensus Estimate. For the third quarter, Olin expects adjusted EBITDA in the range of $160 million to $200 million. OLN expects its Chemical businesses’ results to be comparable with second-quarter levels as lower operating rates at the Freeport vinyl chloride monomer facility and weaker ethylene dichloride pricing offset anticipated stronger caustic soda volumes.

Published in